NEW YORK, August 6, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Cimarex Energy Co. (NYSE: XEC), ArcelorMittal SA (NYSE: MT), Marathon Oil Corporation (NYSEQ: MRO), Range Resources Corp. (NYSE: RRC) and Air Products & Chemicals, Inc. (NYSE: APD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5499-100free.
Cimarex Energy Co. Research Reports
On August 1, 2014, Cimarex Energy Co.'s (Cimarex) stock declined 1.38% to end the trading session at $137.10, following the S&P 500 which declined 0.29% over the same trading session. Cimarex's stock opened the session at $137.62 and fluctuated between $138.12 and $134.59. However, over the past three months the stock has returned 15.77%, outperforming the S&P 500 that returned 2.34% over the same period. The full research reports on Cimarex are available to download free of charge at:
http://www.analystsreview.com/Aug-06-2014/XEC/report.pdf
ArcelorMittal SA Research Reports
On July 24, 2014, ArcelorMittal SA (ArcelorMittal) announced that its plant in Germany, ArcelorMittal Bottrop, has invested in an advanced electrical power unit which not only produces electricity but also doubles up as a pressure reducing station. The Company informed that new plant known as Energy Module was supplied by ENVA Systems GmbH. Further, the plant partially substitutes a pressure reducing station (in which the pressure of the incoming steam is reduced) and uses the resulting energy to produce electricity for the coking plant's wash water treatment. In addition, the plant also supplies energy to coking plant's power grid which is used by various machines, plant sections, and pumps. The Company stated that the new unit is capable of producing 80 KW (Kilowatt) of energy per hour. In addition, the new unit also reduces operating costs as it eliminates the need of steam turbines which are more expensive and require more maintenance. The full research reports on ArcelorMittal are available to download free of charge at:
http://www.analystsreview.com/Aug-06-2014/MT/report.pdf
Marathon Oil Corporation Research Reports
On July 30, 2014, Marathon Oil Corporation (Marathon Oil) announced that its Board has approved an increment of 10.5% QoQ to $0.21 per share in the Company's quarterly dividend. Marathon Oil informed that the dividend will be paid on September 10, 2014 to its common stock holders of record on August 20, 2014. The full research reports on Marathon Oil are available to download free of charge at:
http://www.analystsreview.com/Aug-06-2014/MRO/report.pdf
Range Resources Corp. Research Reports
On July 28, 2014, Range Resources Corp. (Range Resources) released its Q2 2014 and H1 2014 financial results. The Company reported Q2 2014 total revenues and other income of $765.5 million, up 13.7% YoY, surpassing the Zacks consensus revenue estimate of $501 million. Average daily production increased by 21.4% YoY to 1.1 Bcfe per day. Q2 2014 net income came in at $171.4 million or $1.04 per diluted share, compared to $144.0 million or $0.88 per diluted share in Q2 2013. The Company's H1 2014 total revenues and other income improved 23.2% YoY to $1.2 billion. H1 2014 net income came in at $203.9 million or $1.24 per diluted share, compared to $68.4 million or $0.42 per diluted share in H1 2013. For Q3 2014, Range Resources expects production growth at 25% YoY, while average daily production is expected to be approximately 1.20 Bcfe per day. The full research reports on Range Resources are available to download free of charge at:
http://www.analystsreview.com/Aug-06-2014/RRC/report.pdf
Air Products & Chemicals, Inc. Research Reports
On July 23, 2014, Air Products & Chemicals, Inc. (Air Products) reported its Q3 FY 2014 earnings (period ended June 30, 2014). The Company reported sales of $2.6 billion, up 3.4% YoY, driven by higher volumes across all business segments. During the quarter, the Company's operating income improved 8.0% YoY to $413.8 million, driven by higher volumes in Electronics and Performance Materials and better pricing in Merchant Gases. Q3 FY 2014 net income attributable to Air Products came in at $314.0 million or $1.46 per diluted share, compared to $288.4 million or $1.36 per diluted share in Q3 FY 2013. For Q4 FY 2014, the Company expects EPS from continuing operations in the range of $1.60 to $1.65, while for full-year FY 2014 the same is anticipated to be between $5.72 and $5.77. Thefull research reports on Air Products are available to download free of charge at:
http://www.analystsreview.com/Aug-06-2014/APD/report.pdf
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
EDITOR'S NOTES:
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
